Combating Moderate-to-Severe Pediatric Atopic Dermatitis: Considerations for Pharmacists
Combating Moderate-to-Severe Pediatric Atopic Dermatitis: Considerations for Pharmacists is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.
Published: May 31, 2023
Expires: May 31, 2024
Goal:
To provide pharmacists with updated knowledge on the pathophysiology, epidemiology, and signs and symptoms of moderate-to-severe atopic dermatitis in pediatric patients, including the appropriate use of newly approved therapeutic agents and the management of this chronic disease, leading to improved patient outcomes and a better quality of life.
Educational Objectives:
At the conclusion of the activity, the learner will be able to:
• Explain the pathophysiology, epidemiology, and signs and symptoms of moderate-to-severe atopic dermatitis (AD) in the pediatric population
• Describe the new AD therapies approved for moderate to-severe disease for pediatric patients and their roles in controlling this chronic condition to improve treatment outcomes
• Identify strategies to optimally counsel AD pediatric patients and their caregivers, including promoting safe use and optimal treatment adherence, to enhance quality of life for patients with moderate-to-severe disease
Additional details will be posted as soon as information is available.